The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis.

In this eBlog, discover how sequencing-based methods provide a complete view of RNA quality, enabling confident assessment of identity, purity, and integrity to support both research and regulatory readiness.

Direct RNA sequencing provides unique insights into RNA biology. Learn more about how this technology is being applied to advance discovery and ensure rigorous quality control for RNA medicines.

The 5th Annual mRNA Therapeutics Summit brought together leaders from biotech, pharma, and academia to discuss the breakthroughs shaping RNA medicines and the bottlenecks that remain. Our recap highlights key takeaways, emerging opportunities, and the trends likely to define the next decade of RNA therapeutic development.

Micropeptides, proteins under 100 amino acids, are emerging regulators of cancer, metabolism, and neurodegeneration. Learn how ribosome profiling can reveal these hidden proteins, driving the discovery of new biomarkers and development of novel therapeutics.